LENZ THERAPEUTICS, INC. (LENZ) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00K; Additional Paid in CapitalUSD $520.44M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-629.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00K; Additional Paid in CapitalUSD $515.57M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-450.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00K; Additional Paid in CapitalUSD $511.24M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $242.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $1.00K; Additional Paid in CapitalUSD $384.94M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $227.00K.
LENZ THERAPEUTICS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $1.00K | $520.44M | $-629.00K | $-300.55M | $219.26M | 3 month · $4.47M | (m) |
| 2026-03-31 | $0.00 | $1.00K | $515.57M | $-450.00K | $-268.63M | $246.49M | 3 month · $4.32M | (m) |
| 2025-12-31 | $0.00 | $1.00K | $511.24M | $242.00K | $-227.14M | $284.34M | 12 month · $12.55M | (m) |
| 2025-09-30 | (m) | $1.00K | $384.94M | $227.00K | $-191.25M | $193.93M | 3 month · $3.47M | (m) |
| 2025-06-30 | (m) | $1.00K | $380.87M | $38.00K | $-174.54M | $206.37M | 3 month · $2.85M | (m) |
| 2025-03-31 | (m) | $1.00K | $351.52M | $123.00K | $-159.63M | $192.01M | 3 month · $2.56M | (m) |
| 2024-12-31 | $0.00 | $1.00K | $348.90M | $196.00K | $-145.01M | $204.08M | 12 month · $6.37M | 12 month · $1.92M |
| 2024-09-30 | (m) | $0.00 | $347.12M | $523.00K | $-132.36M | $215.28M | 3 month · $2.19M | (m) |
| 2024-06-30 | (m) | $0.00 | $315.13M | $-62.00K | $-122.15M | $192.92M | 3 month · $1.60M | (m) |
| 2024-03-31 | (m) | $0.00 | $310.06M | $-1.00K | $-111.89M | $198.17M | 3 month · $947.00K | 3 month · $1.92M |
| 2024-03-22 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.90M |
| 2023-12-31 | $0.00 | $10.00K | $2.52M | $6.00K | $-95.25M | $-92.71M | 12 month · $1.34M | (m) |
| 2023-09-30 | $0.00 | $1.00K | $548.25M | $-95.00K | $-344.14M | $-69.57M | 3 month · $494.00K | (m) |
| 2023-06-30 | $0.00 | $1.00K | $546.07M | $-271.00K | $-321.65M | $-51.21M | 3 month · $189.00K | (m) |
| 2023-03-31 | $0.00 | $1.00K | $543.03M | $-469.00K | $-266.34M | $-36.68M | 3 month · $142.00K | (m) |
| 2022-12-31 | $0.00 | $1.00K | $539.74M | $-1.05M | $-242.40M | $-24.17M | 12 month · $13.53M | (m) |
| 2022-09-30 | $0.00 | $1.00K | $535.85M | $-1.60M | $-217.80M | $316.45M | 3 month · $3.21M | (m) |
| 2022-06-30 | $0.00 | $1.00K | $532.61M | $-1.03M | $-193.12M | $338.46M | 3 month · $3.36M | (m) |
| 2022-03-31 | (m) | $1.00K | $528.79M | $-309.00K | $-167.19M | $361.30M | 3 month · $3.34M | (m) |
| 2021-12-31 | $0.00 | $1.00K | $525.40M | $0.00 | $-141.35M | $384.05M | 12 month · $7.87M | (m) |
| 2021-09-30 | (m) | $1.00K | $522.55M | (m) | $-122.42M | $400.13M | 3 month · $2.37M | (m) |
| 2021-06-30 | (m) | $1.00K | $487.01M | (m) | $-107.83M | $379.18M | 3 month · $2.02M | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | $-84.08M | 3 month · $1.03M | (m) |
| 2020-12-31 | (m) | (m) | $5.18M | (m) | $-70.59M | $-65.41M | 12 month · $177.00K | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | $-4.79M | 3 month · $36.00K | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | $-1.45M | 3 month · $1.00K | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $-2.36M | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $-2.22M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |